Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Recigen 44µg

This product is the most expensive of its product family


May be acceptable
If it is considered to be clearly essential

May be acceptable
Recigen 44µg :
Type Medicine Authorised
Note Medicine registered upon Minister decision
Originator Rebif 44µg Syringes
Agent Lebiran
Distributor Lebiran
Laboratory CinnaGen
Responsible Party Cinnagen Co
Origin Iran
Manufacturer CinnaGen Co
Manufacturing Type G
Origin Iran
ATC L03AB07

Your comment will appear shortly after approval

Recigen 44µg :

Revision Date : 26/08/2014


Effect Frequency
Alopecia Common
Anaemia Very Common
Anaphylactic reactions Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Anxiety Not known
Arrhythmia Not known
Arthralgia (Pain joint) (Joint ache) Common
Autoantibody positive Not known
Autoimmune hepatitis Rare
Chills Common
Decreased appetite Not known
Depression Common
Diarrhoea (Diarrhea) Common
Dizziness Not known
Dyspnoea (dyspnea) Uncommon
Embolism Uncommon
Erythema multiforme Rare
Fatigue Common
Gait disturbance Not known
Glomerulosclerosis Rare
Haemolytic uraemic syndrome (HUS) Rare
Headache Very Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Rare
Hepatitis Uncommon
Hyperthyroidism Uncommon
Hypoesthesia Not known
Hypothyroidism Uncommon
Influenza-like illness Very Common
Injection site abscess Uncommon
Injection site cellulitis Rare
Injection site infection Uncommon
Injection site inflammation Very Common
Injection site mass Uncommon
Injection site necrosis Uncommon
Injection site pain Common
Injection site reaction Very Common
Insomnia Common
Jaundice Not known
Leucopenia (Leukopenia) Very Common
Lupus-like syndrome Rare
Lymphopenia Very Common
Maculopapular rash Common
Menorrhagia Not known
Metrorrhagia Not known
Muscle spasms Not known
Musculoskeletal stiffness Not known
Myalgia Common
Nausea Common
Nephrotic syndrome Rare
Neurological symptom Not known
Neutropenia Very Common
Palpitations Not known
Pancytopenia Rare
Paraesthesia (paresthesia) Not known
Pruritus Common
Pyrexia Common
Rash erythematous Common
Retinal artery occlusion Uncommon
Retinal exudates Uncommon
Retinal vascular disorders Uncommon
Retinal vein occlusion Uncommon
Retinopathy Uncommon
Seizures Uncommon
Skin rash Common
Stevens-Johnson syndrome Rare
Suicide attempt Rare
Thrombocytopenia (Thrombopenia) Very Common
Thrombotic microangiopathy Rare
Thrombotic thrombocytopenic purpura (TTP) Rare
Thyroid disorder Uncommon
Transaminases increased Very Common
Urticaria Uncommon
Vasodilation procedure Not known
Vomiting Common

Different Units By MoH Code

Recigen 44µg  MoH 10088 :
Form Solution for injection
Packaging Pre-filled Syringe
Package Size 4x0.5ml
Strength (12MIU) 44µg/0.5ml
Public Price 1863477 L.L.
Stratum E1
NSSF ✘
Quarantine ✘
Reg. Number 139419/1
Submission date 18/09/2019
Registration Year 07/11/2019
Pending Year 25/09/2019


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 4x0.5ml
● Public Price: 1863477 LBP ( 1,863,477.00 LBP )
● Pack size unit used: 4
● Cost/Unit: 465869,25 LBP ( 465,869.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info